About 58 percent of the $2 billion in notes were placed with investors in the U.S., Naratil said in a phone interview today. Another third was sold in Europe, including Switzerland, and the rest in Asia, he said. Institutional investors such as asset managers took up about 70 percent, he said.
The 10-year securities, which carried a 7.625 percent coupon, will be written off if UBS’s common equity ratio falls below 5 percent or the bank faces a bailout.
Under Swiss rules, UBS and Credit Suisse Group AG (CSGN) need to hold contingent capital with a 5 percent trigger amounting to 6 percent of risk-weighted assets. That means UBS may need to raise a total of about 14.4 billion Swiss francs ($14.8 billion) in contingent capital if it cuts risk-weighted assets to the targeted 240 billion francs. Last week’s sale adds to $2 billion of such notes sold in February.
Last week’s sale was the first one offered to U.S. investors after the bank received indications of interest from institutional and wealth management clients there following the sale of the February contingent capital bond, Naratil said. “And we did see quite a strong demand from the U.S.,” he added.
“Investors in the U.S. were very quick to get up to speed,” Naratil said. “There weren’t very many questions. A lot of it I think had to do with comfort about our capital position more than anything else.”
UBS’s capital ratio for triggering the contingent capital bonds will be calculated under the prevailing regulatory rules. The company has to satisfy Basel 2.5 rules until the end of this year, and then adopt various Basel III changes as they are phased in. The bank’s core Tier 1 ratio under Basel 2.5 rules at the end of June was 17.2 percent, which was equivalent to a common equity ratio of 13.1 percent under phased-in Basel III rules.
The coupon on the bonds, which was higher than 7.25 percent on the February issue, reflected market conditions rather than the downgrade by Moody’s Investors Service of UBS’s credit rating in June, Naratil said. The rating company lowered UBS by two levels instead of the maximum three-level downgrade it had considered.
UBS will continue to sound out the market to decide whether to hold another contingent capital note sale later this year, Naratil said, adding that it’s “reasonable to expect” two to three such sales a year to get the bank to fulfill regulatory requirements ahead of schedule.
To contact the reporter on this story: Elena Logutenkova in Zurich at firstname.lastname@example.org
To contact the editor responsible for this story: Frank Connelly at email@example.com